Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ikapharmindo Putramas Tbk. (IKPM) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Ikapharmindo Putramas Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Ikapharmindo Putramas Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp195 (market cap 330.19B, 100 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B, 300 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (300 versus 100). Which is the better fit depends on your goals.

IKPMLABS
Market Cap
330.19B651.75B
Volume
100300
Lot
13
Turnover
19.5K49.5K
Average Price
195165
Value
19.5K49.5K
Indicative Equilibrium Price
195165
Indicative Equilibrium Volume
1300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKPM
View details
LABS
View details

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS